Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 516 followers
Latest posts
Last updated 12 days ago
Human medicines European public assessment report (EPAR): mNexspike, COVID-19 mRNA vaccine, Status: Opinion
12 days ago
Human medicines European public assessment report (EPAR): mNexspike, COVID-19 mRNA vaccine, Status...
Human medicines European public assessment report (EPAR): Aumseqa, Aumolertinib, Status: Opinion
12 days ago
Human medicines European public assessment report (EPAR): Aumseqa, Aumolertinib, Status: Opinion
Human medicines European public assessment report (EPAR): Anktiva, nogapendekin alfa inbakicept, Status: Opinion
12 days ago
Human medicines European public assessment report (EPAR): Anktiva, nogapendekin alfa inbakicept, Status...
Human medicines European public assessment report (EPAR): Myqorzo, aficamten, Status: Opinion
12 days ago
Human medicines European public assessment report (EPAR): Myqorzo, aficamten, Status: Opinion
Human medicines European public assessment report (EPAR): Gotenfia, golimumab, Status: Opinion
12 days ago
Human medicines European public assessment report (EPAR): Gotenfia, golimumab, Status: Opinion
Human medicines European public assessment report (EPAR): Ranluspec, ranibizumab, Status: Opinion
12 days ago
Human medicines European public assessment report (EPAR): Ranluspec, ranibizumab, Status: Opinion
Human medicines European public assessment report (EPAR): Blarcamesine Anavex, blarcamesine, Status: Opinion
12 days ago
Human medicines European public assessment report (EPAR): Blarcamesine Anavex, blarcamesine, Status: Opinion
Human medicines European public assessment report (EPAR): Exdensur, depemokimab, Status: Opinion
12 days ago
Human medicines European public assessment report (EPAR): Exdensur, depemokimab, Status: Opinion
Human medicines European public assessment report (EPAR): Ondibta, insulin glargine, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Ondibta, insulin glargine, Status: Opinion
Human medicines European public assessment report (EPAR): Osqay, denosumab, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Osqay, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Aqneursa, L-acetylleucine, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Aqneursa, L-acetylleucine, Status: Opinion
Human medicines European public assessment report (EPAR): GalenVita, germanium (68Ge) chloride,gallium (68Ga) chloride, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): GalenVita, germanium (68Ge) chloride,gallium (68Ga)...